Kingdon Capital Management »

Syndax Pharmaceuticals shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 746k 21.61

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Blackstone Group Inc Com Cl A Put Option (BX)
Sherwin-Williams Company Call Option (SHW)
Api Group Corp Com Stk (APG)
Catalent (CTLT)
Rapt Therapeutics (RAPT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teck Resources CL B (TECK)
Meta Platforms Cl A (META)
Ftai Aviation SHS (FTAI)
Union Pacific Corporation (UNP)
Molson Coors Beverage CL B (TAP)
Synchrony Financial Put Option (SYF)
Bank of America Corporation Call Option (BAC)
Dell Technologies CL C (DELL)

View all positions for Kingdon Capital Management

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals